Labor Pain
Conditions
Keywords
Labor analgesia, Nitrous Oxide, Meperidine, Multiparous, Visual analogue scale
Brief summary
Systematic opioids and inhaled nitrous oxide (N2O ) are common methods for pain relief during labor. The aim of the current study is to evaluate the efficacy of systemic pethidine compared to N2O given for pain relieve in term, multiparous women in labor.
Detailed description
Pain relief during labor and delivery is an essential part of good obstetrical care. Labor pain and its relief have implications on the course of labor, maternal and fetal outcomes and the satisfaction with childbirth overall. Many women would like to have a choice in pain relief during labor but also would like to avoid invasive methods of pain management in labor (as epidural). Both, inhaled analgesia and parenteral opioids are common pharmacological interventions aim to relieve the pain of labor.Nitrous oxide in a 50/50 mix with oxygen is the most common concentration used for labor pain management. It is self-administered via facemask, intermittently, and has rapid onset and offset effect. Main side effects, including nausea, vomiting, dizziness and drowsiness. Pethidine is one of the most frequently used opiate agonists. It can be given intravenous or intramuscularly. Its analgesic effect starts within 10-20 minutes and lasts 2-4 hours. Reported maternal side effects include nausea, vomiting and dysphoria. Pethidine may lead to changes in fetal heart rate tracing during labor, respiratory depression, impaired sucking reflex and restlessness. Given the fact that these two routine interventions are given in different ways and have different side effects profile, the investigators aim in this randomized controlled trial to compare the analgesic effect of these two methods and their maternal and perinatal secondary effects in multiparous laboring women.
Interventions
DRUGIV Meperidine
Intravenous meperidine 50mg in 100cc NaCl 0.9% . Repeated doses (if needed): intervals of 2 hours minimum until a maximum of 4 doses. In cases of nausea or vomiting intravenous metoclopramide 10mg will be offered to the parturient. If pain intensity (according to visual analogue scale), 20 to 30 minutes from administration, will not decline or the parturient will ask for a different type of analgesia, inhaled nitrous oxide or epidural analgesia will be offered.
DRUGNitrous Oxide
Nitrous oxide in a 50/50 mix with oxygen given via self-administered face mask. The parturient will be advised to place the mask tightly on her face and to breathe through it at the first sign of forthcoming uterine contraction. Between contractions, she will be advised not to breathe through the mask. In cases of nausea or vomiting intravenous metoclopramide 10mg will be offered to the parturient. If pain intensity (according to visual analogue scale), 20 to 30 minutes from administration, will not decline or the parturient will ask for a different type of analgesia, intravenous meperidine or epidural analgesia will be offered.
Sponsors
HaEmek Medical Center, Israel
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
1. Multiparity (para 2 or more). 2. Term pregnancy: 37-42 weeks of gestation. 3. Singleton pregnancy. 4. Vertex presentation. 5. In labor: at least 2 contraction in ten minutes and cervical dilatation of 2 centimeters or more.
Exclusion criteria
1. Women who desire epidural as a first line analgesia during labor. 2. Women receiving pethidine during the last 24 hours (prior to entering labor room). 3. Contra-indication for vaginal delivery. 4. Contra-indication or allergic reaction to either pethidine or nitrous oxide. 5. History of drug abuse. 6. Previous cesarean delivery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | 20-30 minutes after drug administration. | Visual analogue scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time from drug administration to labor. | 24 hours | — |
| Need for additional analgesia | 24 hours | Number of women that needed additional analgesia. |
| Side effects. | During 60 minutes from drug administration. | nausea, vomiting, itching, headache, mouth dryness, drowsiness |
| Breast feeding | Up to 48 hours after birth | — |
| Participants satisfaction and the usefulness of pain relief | Within 48 hours after birth | Scale of excellent, very good, good, fair or poor. |
| Pain intensity | 60, 120 and 180 minutes from drug administration. | Visual analogue scale |
| Occurence of meconium stained amniotic fluid | 24 hours | Number of women with meconium stained amniotic fluid. |
| Umbilical artery PH | Up to 5 min from birth, after performing cord clamping. | Number of women with Umbilical artery PH less than 7.1. |
| Apgar score | At 1 and 5 minutes after birth | — |
| Need for respiration | Within 48 hours after birth | — |
| Neonatal Intensive Care Unit (NICU) administration | Within 48 hours after birth | Number of neonates that admitted to neonatal intensive care unit within 48 hours after birth. |
| Changes in electronic fetal heart rate monitoring | 24 hours | — |
Countries
Israel
Outcome results
None listed